2021
DOI: 10.1002/adfm.202102334
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Plain X‐Ray Imaging of Cancer Using Perovskite Quantum Dot Scintillators

Abstract: Real‐time in vivo detection of cancer via attenuation‐based plain X‐ray imaging is proposed to fundamentally overcome the penetration depth limits of current fluorescence‐based imaging techniques. Using cesium lead bromide (CsPbBr3, CPB) quantum dot (QD) scintillators, real‐time X‐ray detection of 5 mm‐sized Panc‐1 cell tumors grown in a mouse is successfully performed. The QDs are rapidly co‐synthesized and double‐encapsulated with silicon dioxide (SiO2) to completely prevent them from being aggregated, decom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(31 citation statements)
references
References 36 publications
(41 reference statements)
0
28
0
Order By: Relevance
“…Comparing these spectra, any detectable PPO signal was not observed for the solution, in which the CPB/SiO 2 NPs were dispersed for 30 days, indicating the high stability of PPO molecules in the NPs. Furthermore, based on the report that most SiO 2 NPs of this size intravenously injected into mice are excreted within 7 days [9], the accumulated PPO or SiO 2 in the body would be much less. Of course, further in-depth evaluation will be required to safely apply this material to in vivo imaging.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Comparing these spectra, any detectable PPO signal was not observed for the solution, in which the CPB/SiO 2 NPs were dispersed for 30 days, indicating the high stability of PPO molecules in the NPs. Furthermore, based on the report that most SiO 2 NPs of this size intravenously injected into mice are excreted within 7 days [9], the accumulated PPO or SiO 2 in the body would be much less. Of course, further in-depth evaluation will be required to safely apply this material to in vivo imaging.…”
Section: Resultsmentioning
confidence: 99%
“…SiO 2 NPs containing CPB QDs and PPO molecules, denoted as CPB-PPO/SiO 2 NPs, were synthesized using a modified "rapid co-synthesis and double-encapsulation method", which was described elsewhere [9]. Briefly, 2 mL CPB precursor solution prepared by adding 0.3 g lead bromide (99.999%; Sigma-Aldrich, Seoul, Korea), 0.17 g cesium bromide (99.999%; Sigma-Aldrich, Seoul, Korea), 1.2 mL oleylamine (70%; Sigma-Aldrich, Seoul, Korea), 3.6 mL oleic acid (90%; Sigma-Aldrich, Seoul, Korea), and catalytic amount of ammonium hydroxide (28%; Deajung, Seoul, Korea) in 20 mL N,N-dimethylformamide (99.5%, Deajung, Seoul, Korea) were rapidly injected into a SiO 2 precursor solution containing 1600 µL tetramethyl orthosilicate (98%; Sigma-Aldrich, Seoul, Korea) and 200 mg PPO (grade for spectrometry; Sigma-Aldrich, Seoul, Korea) in 100 mL toluene (99.7%; Deajung, Seoul, Korea), followed by stirring at room temperature for 2 h. The synthesized CPB-PPO/SiO 2 NPs were collected using centrifugation and washed with ethanol three times, followed by annealing at 150 • C for 2 h to remove surface hydroxyl groups.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…7–10 These characteristics afford metal halide perovskites NCs broad applications in light-emitting diodes (LEDs), solar cells, photodetectors, lasers and biological imaging. 11–20 However, three-dimensional (3D) perovskites have the characteristics of ionic crystals wherein wet and hot conditions lead to phase transition and decomposition of the NCs, which greatly limit their applications in optoelectronics. Therefore, researchers have focused on the development of low-dimensional perovskite derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, screening requires the collection of samples from a large population, whereas early diagnosis requires periodic testing, which is only feasible using non‐invasive methods. Clinical methods for the non‐invasive detection of cancer include medical imaging technologies (such as X‐ray imaging, 2 computed tomography, 3 magnetic resonance imaging, 4 ultrasonic testing 5 and positron emission tomography‐computed tomography 6 ) and serum antigen protein markers. 7 These methods have their strengths; for example medical imaging reveals the location and morphology of tumours, whereas serum antigen protein markers have broad applications.…”
Section: Introductionmentioning
confidence: 99%